BAX and colorectal carcinoma: Reduced expression of Bax was correlated with poor differentiation, metastatic progression, and is a negative prognostic factor in patients with CRC (Sturm et al., 1999; Jansson and Sun, 2002; Ko et al., 2013)It is upregulated in all stage FOLFOX responders compared non-responders.